Warteck Invest AG operates within the Apartment building operators sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Warteck Invest AG with three other
Real estate operators in Europe:
Target Healthcare REIT Ltd
of the United Kingdom
sales of £28.37 million [US$35.33 million]
Fastighets AB Trianon
(348.10 million Swedish Kronor [US$36.22 million]
of which 56%
was Residence), and
Xior Student Housing NV
based in Belgium
(30.25 million Euro [US$33.50 million]
of which 56%
was Netherlands - Students).
During the year ended December of 2018, sales at
Warteck Invest AG were 33.41 million Swiss Francs (US$33.71 million).
increase of 5.3%
versus 2017, when the company's sales were 31.74 million Swiss Francs.
This was the third consecutive year of growth at Warteck Invest AG.
Sales of Housing Property saw an increase
that was more than double the company's growth rate: sales were up
11.9% in 2018, from
13.02 million Swiss Francs to 14.57 million Swiss Francs.
Not all segments of Warteck Invest AG experienced an increase in sales in 2018:
sales of Development Property fell 7.6% to 61,000.00 Swiss Francs.
(However, this segment's sales were only a very small portion of the company's overall sales).